The high incidence of spine fractures in the elderly, coupled with the rapid expansion of this segment of the population in the United States, prompted the recent description of spine fractures in the geriatric population as a serious emerging health care crisis.[@R1] The population of the United States older than 65 years is expected to double to more than 70 million between the years 2000 and 2030,[@R2] and the population older than 85 years is the fastest growing age group, expected to double by 2025 and quintuple by 2050.[@R1],[@R3]

Odontoid fractures are among the most common spine fractures in general, but in the elderly, these injuries are the most common isolated spine fracture.[@R4],[@R5] A majority of these are classified as type II fractures on the basis of the classification by Anderson and D\'Alonzo.[@R6] A recent report has demonstrated that the number and frequency of type II odontoid fractures, in comparison with other spine injuries, seems to be increasing during the past 2 decades and may correlate with the increasing elderly population.[@R7]

There is controversy regarding whether operative or nonoperative management is the best treatment option for elderly patients with type II odontoid fractures.[@R8; @R9; @R10; @R11; @R12] Type II fractures by definition occur through the base of the dens, which in comparison with the body of the C2 vertebra, has a less robust blood supply and bone quality, and together with its high-strain location renders this fracture more vulnerable to nonunion.[@R13] This risk of nonunion seems to be particularly high in the elderly, in which the rate of pseudarthrosis has been reported to be as high as 85% with nonoperative management.[@R14] In contrast, fusion rates of up to 100% have been reported with posterior C1--C2 instrumentation.[@R15] However, surgical treatment in these often medically compromised patients is also associated with adverse outcomes, with a recent report documenting a mortality rate of 19.2% and major complication rate of 27% in an operatively treated cohort of elderly patients with type II odontoid fractures.[@R16]

Adding to the controversy of management of type II odontoid fractures has been uncertainty regarding the clinical significance of chronic fracture nonunion. Reports from Crockard *et al*[@R17] and Kirankumar *et al*[@R18] had raised the concern of delayed myelopathy in the setting of nonunion. However, a case series by Hart *et al*[@R19] suggested that development of delayed myelopathy in the setting of pseudarthrosis of type II odontoid fracture in the elderly to be a rare event. A subsequent report further endorsed a lack of correlation between fracture healing and clinical outcomes.[@R11] Thus, the optimal management of elderly patients with type II odontoid fractures remains controversial, with advocates of both operative and nonoperative approaches.[@R20],[@R21]

Our objectives in this study were to evaluate short- and long-term mortality in geriatric patients with type II odontoid fracture and to assess whether these mortality rates differed significantly based on operative *versus* nonsurgical treatment approach.

MATERIALS AND METHODS
=====================

Patient Population
------------------

Prospectively collected electronic spine trauma databases from 3 large level I trauma centers were used to identify consecutive patients 65 years or older treated for type II odontoid fractures between the years 2003 and 2009. These centers are all members of the AOSpine North America Research Network and included (Harborview Hospital at the University of Washington, Thomas Jefferson University Medical Center, and University of Kansas Medical Center). Although there may be patients who present on a delayed basis in the outpatient clinical setting, this study only included patients who were initially evaluated in the emergency room setting and admitted to the hospital. The medical records of the 322 identified patients were reviewed. This study was approved by the institutional review boards of the participating institutions and the institutional review board of the Data Management Center at (University of Washington).

Data Collection
---------------

Admission, hospital, and clinical follow-up records were retrospectively reviewed for each patient. Extracted data included: age, sex, living arrangement prior to injury (independent *vs*. assisted living facility), mechanism of injury, comorbidities, initial treatment modality (operative *vs*. nonoperative), length of hospital and intensive care unit stay, whether a feeding tube was placed, and discharge disposition. Comorbidity was assessed on the basis of the Charlson comorbidity index (CCI).[@R22] Mortality was assessed using a combination of medical records and the hospital access to death records systems. The abstracted data were transferred to the Data Management Center at (University of Washington) for analysis.

Statistical Analysis
--------------------

Frequency distributions and summary statistics were calculated for demographic, clinical, and operative variables. For categorical variables, cross-tabulations were generated and Fisher exact or Pearson χ2 tests were used to compare distributions. For continuous variables, *t* tests were used to investigate differences in the distribution between operative and nonoperative groups. The Kruskal-Wallis test was used for data that were not normally distributed. Differences in survival between the operative and nonoperative groups were modeled using Cox proportional hazards models to assess the prognostic significance of treatment approach (operative *vs*. nonoperative), including adjustment for age, sex, and CCI. Post-treatment variables were not considered for inclusion into the model because of the potential for introduction of confounding effects related to the treatment. Two Cox models were developed, one for mortality within 30 days of presentation and the other for mortality on the basis of maximum follow-up time. Four covariates (treatment, age, sex, and CCI) were introduced into both mortality Cox models. The maximum follow-up time was defined as time to death for deceased patients or time from injury to date of medical record abstraction for patients who were alive at the time of research (censored observations). Treatment allocation was according to initial treatment. Kaplan-Meier survival plots were created for illustrative purposes for mortality within 30 days and for mortality at the time of maximum follow-up. Statistical analyses were 2-sided, and *P* \< 0.05 was considered statistically significant. All analyses were performed using SAS/STAT version 9.3 (SAS Institute Inc., Cary, NC).

RESULTS
=======

Patient Population
------------------

Average follow-up was 647.5 days (range 0--2456 d) for the nonoperative group and 851.2 days (range 1--2565 d) in the operative group. Patient characteristics and mechanism of injury for the 322 patients are summarized in [Table 1](#T1){ref-type="table"}. The overall mean patient age was 81.8 ± 7.8 years and ranged from 65.0 to 101.5 years. The operatively treated patients were younger than nonoperative patients (80.4 and 83.2 yr, respectively, *P* = 0.0014). The operative and nonoperative treatment groups did not differ significantly in the proportion of males *versus* females (*P* = 0.9395). Prior to the injury, significantly more nonoperative patients were living independently than operative patients (55% *vs*. 34%, *P* \< 0.0001); however, both groups had moderate numbers of patients for whom preinjury living arrangements were not documented. The vast majority of patients (92%) sustained their odontoid fracture from a ground level fall, and this mechanism of injury was significantly more common among surgically treated patients (96%), compared with nonoperative patients (88%) (*P* = 0.0097).

###### Patient Demographics for 322 Geriatric Patients With Type II Odontoid Fracture, Stratified on the Basis of Operative *Versus* Nonoperative Treatment

                                        All (N = 322)   Operative (N = 165)   Nonoperative (N = 157)   *P*
  ------------------------------------- --------------- --------------------- ------------------------ -------------------------------------------
  Age (yr)                              81.8 ± 7.8      80.4 ± 7.7            83.2 ± 7.7               0.0014
  Sex                                                                                                  0.9395
   Male                                 134 (42%)       69 (42%)              65 (41%)                 
   Female                               188 (58%)       96 (58%)              92 (59%)                 
  Living arrangements prior to injury                                                                  \<0.0001
   Independent                          142 (44%)       56 (34%)              86 (55%)                 
   Assisted living facility             44 (14%)        16 (10%)              28 (18%)                 
   Unknown                              136 (42%)       93 (56%)              43 (27%)                 
  Mechanism of injury                                                                                  0.0097
   Fall                                 296 (92%)       158 (96%)             138 (88%)                
   Motor vehicle collision              26 (8%)         7 (4%)                19 (12%)                 
  Hospital length of stay (d)           11.3 ± 15.0     15.0 ± 18.5           7.4 ± 8.7                \<0.0001[\*](#TF1-1){ref-type="table-fn"}
  ICU stay (d)                          1.3 ± 4.1       1.5 ± 4.4             1.1 ± 3.8                0.0008[\*](#TF1-1){ref-type="table-fn"}
  Feeding tube placement                38 (12%)        30 (18%)              8 (5%)                   0.0003
  Discharge disposition                                                                                \<0.0001
   Skilled nursing facility             81 (25%)        32 (19%)              49 (31%)                 
   Home                                 76 (24%)        29 (18%)              47 (30%)                 
   Rehabilitation facility              29 (9%)         17 (10%)              12 (8%)                  
   Homeless                             1 (\<1%)        0 (0%)                1 (1%)                   
   Died                                 30 (9%)         9 (5%)                21 (13%)                 
   Unknown                              105 (33%)       78 (47%)              27 (17%)                 

\**Kruskal-Wallis test*.

ICU indicates intensive care unit.

Compared with the nonoperative treatment group, the operative group have significantly longer mean length of hospital stay (15.0 ± 18.5 *vs*. 7.4 ± 8.7 d, *P* \< 0.0001) and had significantly longer length of stay in the intensive care unit (1.5 ± 4.4 *vs*. 1.1 ± 3.8 d, *P* = 0.0008) ([Table 1](#T1){ref-type="table"}). Operative patients were significantly more likely to be treated with a feeding tube, compared with nonoperatively treated patients (18% *vs*. 5%, *P* = 0.0003). The discharge disposition for the overall population included skilled nursing facility for 25%, home for 24%, rehabilitation facility for 9%, and death for 9%. Both operative and nonoperative patient groups had moderate numbers of patients for whom discharge disposition was not documented, which limits the ability to provide definitive comparisons between the groups with regard to this parameter.

The CCI and rates of specific comorbidities are summarized in [Table 2](#T2){ref-type="table"}. The most common comorbidity was hypertension (33%). None of the rates of the specific comorbidities assessed differed significantly between the operative and nonoperative groups. The mean CCI also did not differ significantly between the operative and nonoperative groups (1.1 ± 1.5 and 1.4 ± 1.5, respectively; *P* = 0.11).

###### Baseline Comorbidities by Treatment for 322 Geriatric Patients With Type II Odontoid Fracture, Stratified on the Basis of Operative *Versus* Nonoperative Treatment

                                           All (N = 322)   Operative (N = 165)   Nonoperative (N = 155)   *P*
  ---------------------------------------- --------------- --------------------- ------------------------ --------
  Charlson comorbidity score               1.2 ± 1.5       1.1 ± 1.5             1.4 ± 1.5                0.11
  Comorbidity                                                                                             
   Chronic obstructive pulmonary disease   37 (11%)        14 (8%)               23 (15%)                 0.0829
   Congestive heart failure                49 (15%)        20 (12%)              29 (18%)                 0.1128
   Dementia                                48 (15%)        22 (13%)              26 (17%)                 0.4164
   Diabetes                                52 (16%)        22 (13%)              30 (19%)                 0.1592
   Hypertension                            106 (33%)       49 (30%)              57 (36%)                 0.2072
   Myocardial infarction                   16 (5%)         9 (5%)                7 (4%)                   0.6810
   Other                                   187 (58%)       83 (50%)              104 (66%)                0.0038

Short-term (30-day) Mortality Analysis
--------------------------------------

Within 30 days of presentation, 46 of the 322 (14%) patients overall had died. This included 11 (7%) operatively treated patients and 35 (22%) nonoperatively treated patients (Fisher exact *P* \< 0.0001) ([Table 3](#T3){ref-type="table"}). The rates of mortality for males and females at 30-day follow-up did not differ significantly (13% and 15%, respectively; *P* = 0.7119). The hazard ratio of death within the first 30 days of presentation in nonoperatively treated patients compared with operatively treated patients was 3.00 (95% \[confidence interval\] CI = 1.51--5.94, P = 0.0017), reflecting significantly poorer survival among nonoperatively treated patients. This analysis was performed with adjustment for the effects of patient age, sex, and CCI ([Table 4](#T4){ref-type="table"}, [Figure 1](#F1){ref-type="fig"}).

![Kaplan-Meier plot of 30-day survival from presentation stratified based on operative versus nonoperative treatment for 322 geriatric patients with type II odontoid fracture.](spne-38-1098-g001){#F1}

###### 30-day Mortality Rates for 322 Geriatric Patients With Type II Odontoid Fracture, Stratified on the Basis of Sex and Operative *Versus* Nonoperative Treatment

  Variable        Died (N = 46)   Alive (N = 276)   *P*
  --------------- --------------- ----------------- ----------
  Sex                                               0.7119
   Male           18 (13%)        116 (87%)         
   Female         28 (15%)        160 (85%)         
  Treatment                                         \<0.0001
   Operative      11 (7%)         154 (93%)         
   Nonoperative   35 (22%)        122 (78%)         

###### Survival Adjusted for Age, Sex, and Charlson Comorbidity Index at 30-day Follow-up and at Maximum Follow-up for 322 Geriatric Patients With Type II Odontoid Fracture

  Variable                                       Hazard Ratio   95% CI       *P*
  ---------------------------------------------- -------------- ------------ ----------
  30-day mortality                                                           
   Management (nonoperative *vs*. operative)     3.00           1.51--5.94   0.0017
   Age (yr)                                      1.10           1.05--1.14   \<0.0001
   Male                                          1.13           0.62--2.08   0.6804
   Charlson comorbidity index                    1.14           0.95--1.36   0.1593
  Mortality at maximum follow-up                                             
   Management (nonoperative   *vs*. operative)   1.35           0.97--1.89   0.0793
   Age (yr)                                      1.07           1.05--1.10   \<0.0001
   Male                                          1.55           1.10--2.16   0.0118
   Charlson comorbidity index                    1.28           1.16--1.40   \<0.0001

CI indicates confidence interval.

Long-term Mortality Analysis
----------------------------

Altogether, there were 661.3 patient-years of follow-up (2.05 yr on average, in the range of 0 d to 7.02 yr). Of these, 276.74 patient-years were from nonoperative patients and 384.51 person-years were from operative patients. At maximum follow-up, 142 of 322 (44%) patients overall had died (21.5 per 100 person-years). This included 62 (38%) of the operatively treated patients and 80 (51%) of the nonoperatively treated patients (*P* = 0.016; [Table 5](#T5){ref-type="table"}). The mortality rate for males (52%) was significantly higher than that of females (38%; *P* = 0.013). After adjusting for the effects of patient age, sex, and CCI, patients treated operatively had a nonsignificant trend toward lower risk of mortality at the time of last assessment, compared with patients treated nonoperatively (HR = 1.35, 95% CI = CI = .97--1.89, *P* = 0.0793) ([Table 4](#T4){ref-type="table"}, [Figure 2](#F2){ref-type="fig"}).

![Kaplan-Meier plot of survival at maximum follow-up from presentation stratified based on operative versus nonoperative treatment for 322 geriatric patients with type II odontoid fracture.](spne-38-1098-g002){#F2}

###### Overall Mortality Rates for 322 Geriatric Patients With Type II Odontoid Fracture at Maximum Follow-up, Stratified on the Basis of Sex and Operative *Versus* Nonoperative Treatment

  Variable        Died (N = 142)   Alive (N = 180)   *P*
  --------------- ---------------- ----------------- -------
  Sex                                                0.013
   Male           70 (52%)         64 (48%)          
   Female         72 (38%)         116 (62%)         
  Treatment                                          0.016
   Operative      62 (38%)         103 (62%)         
   Nonoperative   80 (51%)         77 (49%)          

DISCUSSION
==========

Despite a large number of publications, optimal management of odontoid fractures in the elderly remains controversial.[@R23; @R24; @R25] On the basis of a systematic review of the literature, Harrop *et al*[@R26] recently recommended that type II odontoid fractures in this population should be treated operatively, but the quality of evidence supporting this recommendation ranged from very low to low. However, whether the potential risks of morbidity and mortality incurred by operative treatment are offset by improvements in outcome is an unsettled issue.[@R19],[@R27; @R28; @R29; @R30]

This study provides an assessment of 30-day and long-term mortality rates for a cohort of 322 elderly patients with type II odontoid fracture, including stratification based on operative *versus* nonoperative treatment approach. The findings demonstrate high general rates of mortality in this patient population, specifically 14% within 30 days of presentation. After adjusting for the effects of patient age, sex, and CCI, operatively treated patients had a significantly better 30-day survival rate compared with nonoperatively treated patients. At maximum follow-up, patients treated operatively had a nonsignificant trend toward lower risk of mortality compared with patients treated nonoperatively.

Collectively, these data, demonstrate that surgical treatment of type II odontoid fracture in this elderly population did not negatively impact survival, even after adjusting for patient age and comorbidities, and, that operative treatment may be associated with a significant 30-day survival advantage compared with nonoperatively treated patients. The observation that this survival advantage seems to diminish to the level of a nonsignificant trend during longer term follow-up may relate to a dilutional effect of deaths occurring due to unrelated comorbid conditions in both groups of this elderly population. It is also important to recognize that, although the mortality rates between the operative and nonoperative treatment groups were not significantly different at longer-term follow-up, our data do not permit assessment for potential differences between the groups with regard to neurological or functional status.

White *et al*[@R25] recently performed a meta-analysis of elderly patients treated surgically for type II odontoid fracture and reported overall, in-hospital, postdischarge, and 12-month mortality rates of 10.1%, 6.2%, 8.8%, and 7.7%, respectively.[@R25] The surgically treated patients in this study had 30-day and 12-month follow-up mortality rates of 7% and 26%, respectively. Although the 30-day mortality rate for surgically treated patients from this study is comparable with the postdischarge mortality rate from the systematic review of White *et al*.[@R25] (7% *vs*. 8.8%, respectively), the 12-month mortality rate of this study is substantially higher than the 12-month mortality rate reported by White *et al*[@R25] (26% *vs*. 7.7%). This difference is likely due to inconsistencies and limitations in the 12-month mortality rate reported by White *et al*.[@R25] Their data are based on 12 small, mostly retrospective studies with differing methodological and reporting approaches, thus limiting the reliability of the reported 12-month estimate. The largest study in the systemic review of White *et al*[@R25] had only 75 patients, with many having fewer than 20 patients, and several of the studies had exclusion criteria that could artificially lower mortality rates.[@R31; @R32; @R33; @R34; @R35; @R36; @R37]

Based on a recent systematic review from Harrop *et al*,[@R26] the rates of mortality for nonoperative care for type II odontoid fractures in the elderly range from 4% to 42%. These rates were based on studies with typically low numbers of patients and varying lengths of follow-up. The 30-day and maximum follow-up rates of mortality in this study for patients treated nonoperatively were 22% and 51%, respectively. Our reported rates are toward the higher end of the range reported by Harrop *et al*[@R26] and may reflect our specific emphasis on collecting mortality events in this study.

Few previous studies provide direct comparison of mortality rates between operative and nonoperative care for elderly patients with type II odontoid fractures.[@R38] Smith *et al*[@R34] reported similar in-hospital mortality rates for 72 octogenarians with type II odontoid fractures treated operatively or nonoperatively (mortality rates of 15% and 12.5%, respectively). Chen *et al*[@R39] compared 28 surgically and 28 nonsurgically treated elderly patients with type II odontoid fracture and reported no significant differences in 30-day survival (3.6% *vs*. 7.1%, respectively, *P* \> 0.05) or longer-term survival at a mean of approximately 200 days. Schoenfeld *et al*[@R40] compared 112 nonoperatively treated with 44 operatively treated type II odontoid fractures in elderly patients, and reported higher 3-month mortality (25% *vs*. 11%) and 1-year mortality (36% *vs*. 21%) in nonoperatively treated patients. Fagin *et al*[@R27] assessed 108 elderly patients with odontoid fracture and reported that nonoperative and operative treatment approaches were associated with similar short-term mortality and concluded that nonoperative management should be given strong consideration in these patients.

It is important to recognize potential limitations of this study in order to add context to the interpretation of the data and to highlight important factors for future studies. The most significant limitation is the retrospective design, which limits the ability to assess and control for potential biases in the decision of treatment approach. It is possible that modest trends of increased age and comorbidities could have negatively impacted survival among the nonoperative patients. In addition, our data do not enable assessment of neurological and functional status at follow-up, which may differ between the treatment groups. This study does not include assessment of complication rates (except for mortality) associated with either treatment approach, although there was a significantly greater incidence of feeding tube placement in operatively treated patients. This study suggests that a greater number of patients treated operatively were able to be discharged to home compared with nonoperatively treated patients; however, the retrospective design limited our ability to collect this parameter for a substantial number of patients, which considerably limits the ability to draw conclusions on the basis of this finding. Lastly, although the longer hospital and intensive care unit stay in the operatively treated group suggests that operative treatment may have greater short-term cost compared with nonoperative treatment, this study does not provide assessment of potential long-term cost differences between the treatment groups. However, this study may offer important insights into the ongoing controversies. This study is of a larger group of patients than previously reported with a greater emphasis on patient survival. After adjustment for patient comorbidities, there is a suggestion that at least short-term survival of elderly patients is improved with surgical care. Also, nonsurgical care is not benign. While it is clear that there is no simple answer for the treatment of elderly patients, surgical care may improve chances for survival of elderly patients with type II odontoid fractures. Whether operative treatment is associated with improved neurological and functional status warrants further study.

KEY POINTSOdontoid fractures are the most common isolated spine fracture in the elderly, and the majority of these are type II fractures. Patients who sustain these injuries experience high mortality, and their management, whether operative or nonoperative, remains controversial.Operative treatment for geriatric patients with type II odontoid fractures is associated with improved 30-day survival compared with nonoperative treatment, with adjustment for patient age, sex, and comorbidities.Operative treatment for geriatric patients with type II odontoid fractures is associated with a nonsignificant trend toward higher long-term survival compared with nonoperative treatment, with adjustment for patient age, sex, and comorbidities.At a minimum, the findings demonstrate that surgical treatment for type II odontoid fracture in this elderly population did not negatively impact either short- or long-term survival.
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